Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (2.856)

31

Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2009

von Mancl, E. | Kolesar, J. | Vermeulen, L.

32

Current combination chemotherapy regimens for metastatic breast cancer

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2009

von Schwartz, J.

33

Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis : potential for improving testing accuracy and treatment selection

enthalten in: Molecular diagnosis & therapy | 2009

von Spears, M. | Bartlett, J.

34

Bevacizumab and breast cancer : current therapeutic progress and future perspectives

enthalten in: Expert review of anticancer therapy | 2009

von Yang, S.

35

Impact of mutational status of KRAS in the care of patients with colorectal cancer metastasis

enthalten in: Bulletin du cancer | 2009

von Assenat, E. | Ychou, M.

36

Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view

enthalten in: Bulletin du cancer | 2009

von Blons, H. | Laurent-Puig, P.

37

Ustekinumab : lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases

enthalten in: Annals of the New York Academy of Sciences | 2009

von Elliott, M. | Benson, J. | Blank, M. | +4

38

Trastuzumab versus lapatinib : the cardiac side of the story

enthalten in: Cancer treatment reviews | 2009

von Azim, H. | Azim, H. | Escudier, B.

39

KRAS mutational status as a predictor of epidermal growth factor receptor inhibitor efficacy in colorectal cancer

enthalten in: American journal of therapeutics | 2009

von Baynes, R. | Gansert, J.

CommentIn: Am J Ther. 2009 Nov-Dec;16(6):477-9. - PMID 19829092

40

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

enthalten in: Leukemia | 2009

von Osterborg, A. | Foà, R. | Bezares, R. | +8